Screener
10x Genomics, Inc. TXG Balance Sheet Statement
| Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | ||
|---|---|---|---|---|---|---|
| $502.51M+26.4% | $490.29M+30.0% | $473.97M+37.8% | $432.71M+8.7% | $397.71M+4.7% | ||
| $49.52M-0.1% | $49.56M-0.6% | $49.44M+0.2% | $49.58M— | $49.55M+18,320% | ||
| $47.55M-4.9% | $39.03M-25.7% | $47.01M-46.5% | $43.78M-47.6% | $49.98M-45.2% | ||
| $52.62M-23.7% | $53.49M-28.4% | $56.34M-32.2% | $61.96M-34.1% | $68.97M-21.9% | ||
| $674.67M+2.9% | $669.73M+15.5% | $684.45M+17.1% | $659.83M+11.1% | $655.66M+13.2% | ||
| $215.32M-10.2% | $220.59M-10.4% | $226.71M-10.3% | $232.53M-10.1% | $239.71M-9.0% | ||
| $6.92M+53.4% | $4.51M0.0% | $4.51M0.0% | $4.51M0.0% | $4.51M0.0% | ||
| $61.16M+316% | $59.91M+294% | $62.33M+298% | $64.76M+301% | $14.71M-11.7% | ||
| $1.03B+5.1% | $1.02B+12.4% | $1.04B+13.4% | $1.03B+9.6% | $979.97M+5.4% | ||
| $20.69M+29.8% | $17.43M+73.1% | $12.73M-1.4% | $18.07M-31.1% | $15.94M-25.0% | ||
| $23.61M+10.1% | $24.34M+16.2% | $23.9M+15.7% | $22.14M+24.7% | $21.45M+30.5% | ||
| $118.51M+5.6% | $113.6M+5.3% | $153.45M+30.5% | $147.32M+21.5% | $112.22M+1.1% | ||
| $204.52M-1.1% | $201.44M+2.5% | $245.04M+17.5% | $242.24M+12.7% | $206.69M+0.5% | ||
| $2K0.0% | $2K0.0% | $2K0.0% | $2K0.0% | $2K0.0% | ||
| -$1.54B-5.1% | -$1.52B-1.5% | -$1.51B-3.0% | -$1.49B-5.4% | -$1.47B-6.1% | ||
| $825.55M+6.8% | $814.32M+15.2% | $796.33M+12.1% | $785.12M+8.6% | $773.28M+6.8% | ||
| $1.03B+5.1% | $1.02B+12.4% | $1.04B+13.4% | $1.03B+9.6% | $979.97M+5.4% |
FAQ
- What are 10x Genomics, Inc.'s total assets?
- 10x Genomics, Inc. (TXG) holds $1.0B in total assets, up 5.1% year over year.
- How much debt does 10x Genomics, Inc. have?
- 10x Genomics, Inc. carries $78.8M in total debt against $825.5M of shareholders' equity, a debt-to-equity ratio of 0.10.
- How much cash does 10x Genomics, Inc. have?
- 10x Genomics, Inc. holds $502.5M in cash and equivalents.
- Can 10x Genomics, Inc. cover its short-term obligations?
- Its current ratio is 5.69 — current assets exceed current liabilities.
- Where does 10x Genomics, Inc.'s balance sheet data come from?
- Every line is extracted from 10x Genomics, Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
